Drugs / 21% oxygen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04043299 Comparator | Mar → Aug 2020 | fetal brain disruption sequence, perinatal asphyxia | Makerere University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 21% oxygen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04043299 ↗ |
| Route | Other | “via a non re-breather face mask” NCT04043299 ↗ |